Tuberculosis (TB), known as poor man's disease, is caused by Mycobacterium tuberculosis germs that are spread from person to person through the air. TB usually affects the lungs and affects the other parts of the body such as the brain, the kidneys,or the spine. Across the globe, almost two billion people are infected with M.tuberculosis.

PART 01: Executive summary 6

PART 02: Scope of the report 17

PART 03: Research Methodology 22

PART 04: Introduction 25

Key market highlights 25

PART 05: Key pipeline 26

PART 06: Market landscape 29

Market overview 29

Market size and forecast 30

Five forces analysis 32

PART 07: High burden countries (HBCs) 33

Categorization of HBCs 33

PART 08: TB diagnostics 36

Overview 36

PART 09: Market segmentation by disease type 39

Global latent TB market 39

Global active TB market 39

PART 10: Market segmentation by drug class 42

Global first-line anti-TB drugs market 42

Global second-line anti-TB drugs market 43

PART 11: Geographical segmentation 45

TB drugs market in Americas 45

TB drugs market in EMEA 47

TB drug market in APAC 49

PART 12: Market drivers 51

Increase in outbreak of TB-HIV co-infections 51

Emergence of MDR-TB and XDR-TB strains 51

Increasing incidence of TB in Africa and Asia 52

PART 13: Impact of drivers 53

PART 14: Market challenges 54

Insufficient demand and high drug cost in developed

countries 54

Liberal regulations and lack of awareness in developing

countries 54

Limited diagnostic procedures 55

PART 15: Impact of drivers and challenges 56

PART 16: Market trends 57

Increased spending on TB diagnostic kits 57

Focus on development of shorter TB drug regimens 57

Increased focus on TB vaccine development 58

PART 17: Vendor landscape 59

Competitive scenario 59

Key news 59

PART 18: Key vendor analysis 60

Lupin 60

Otsuka Novel Products 63

Pfizer 65

Sandoz 68

Sanofi 70

Other prominent vendors 73

PART 19: Appendix 74

List of abbreviations 74

PART 20: Explore Technavio 75